Three-dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer
出版年份 2016 全文链接
标题
Three-dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer
作者
关键词
-
出版物
Cancer Medicine
Volume 5, Issue 4, Pages 703-710
出版商
Wiley
发表日期
2016-01-14
DOI
10.1002/cam4.630
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment
- (2015) Nataša Anastasov et al. BMC CANCER
- Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids
- (2015) Cristina E. Rodríguez et al. PLoS One
- 3D cell culture systems modeling tumor growth determinants in cancer target discovery
- (2014) Claudio R. Thoma et al. ADVANCED DRUG DELIVERY REVIEWS
- An injectable spheroid system with genetic modification for cell transplantation therapy
- (2014) Satoshi Uchida et al. BIOMATERIALS
- Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
- (2014) John A. Hickman et al. Biotechnology Journal
- Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
- (2014) M M Wattenberg et al. BRITISH JOURNAL OF CANCER
- Gamma-irradiation induces HER-2/neuoverexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab
- (2013) Ioannis F. Voutsas et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Effects of Simultaneous Knockdown of HER2 and PTK6 on Malignancy and Tumor Progression in Human Breast Cancer Cells
- (2013) Natalie Ludyga et al. MOLECULAR CANCER RESEARCH
- Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
- (2012) Maria Vinci et al. BMC BIOLOGY
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors
- (2012) Ines Höfig et al. JOURNAL OF GENE MEDICINE
- Label-free protein profiling of formalin-fixed paraffin-embedded (FFPE) heart tissue reveals immediate mitochondrial impairment after ionising radiation
- (2012) Omid Azimzadeh et al. Journal of Proteomics
- Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures
- (2012) Victor A Levin et al. Proteome Science
- Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells
- (2012) Nataša Anastasov et al. Radiation Oncology
- Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues
- (2011) Maren Drewitz et al. Biotechnology Journal
- Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer
- (2011) Natalie Ludyga et al. Molecular BioSystems
- In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues
- (2010) M Aubele et al. BRITISH JOURNAL OF CANCER
- Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
- (2010) Katri Köninki et al. CANCER LETTERS
- Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue
- (2010) Ian A Cree et al. CURRENT OPINION IN PHARMACOLOGY
- Factors necessary to produce basoapical polarity in human glandular epithelium formed in conventional and high-throughput three-dimensional culture: example of the breast epithelium
- (2009) Cedric Plachot et al. BMC BIOLOGY
- Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
- (2008) Matthew E. Hardee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started